Regional variation in the incidence rate and sex ratio of multiple sclerosis in Scotland 2010–2017: findings from the Scottish Multiple Sclerosis Register

[1]  L. Wilkins.  The prevalence of MS in the United States , 2019, Neurology.

[2]  Ruth Ann Marrie,et al.  The prevalence of MS in the United States , 2019, Neurology.

[3]  J. Hobart,et al.  Validating the portal population of the United Kingdom Multiple Sclerosis Register. , 2018, Multiple sclerosis and related disorders.

[4]  L. Thygesen,et al.  Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women , 2018, Neurology.

[5]  E. Waubant,et al.  Evidence for a causal relationship between low vitamin D, high BMI, and pediatric-onset MS , 2017, Neurology.

[6]  J. Assmus,et al.  Survival and cause of death in multiple sclerosis: a 60-year longitudinal population study , 2017, Journal of Neurology, Neurosurgery, and Psychiatry.

[7]  S. Wild,et al.  Farming, Foreign Holidays, and Vitamin D in Orkney , 2016, PloS one.

[8]  L. Balbuena,et al.  Sunshine, Sea, and Season of Birth: MS Incidence in Wales , 2016, PloS one.

[9]  Alan J. Thompson,et al.  Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity , 2014, Neurology.

[10]  G. Ebers.  Interactions of environment and genes in multiple sclerosis , 2013, Journal of the Neurological Sciences.

[11]  T. MacDonald,et al.  Incidence and prevalence of multiple sclerosis in the UK 1990–2010: a descriptive study in the General Practice Research Database , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[12]  R. Lucas,et al.  Environmental Risk Factors for Multiple Sclerosis: A Review with a Focus on Molecular Mechanisms , 2012, International journal of molecular sciences.

[13]  James F. Wilson,et al.  A new prevalence study of multiple sclerosis in Orkney, Shetland and Aberdeen city , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[14]  Daniela Pohl,et al.  Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study , 2011, The Lancet Neurology.

[15]  L. Blizzard,et al.  Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[16]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[17]  G. Ebers,et al.  The Epidemiology of Multiple Sclerosis in Scotland: Inferences from Hospital Admissions , 2011, PloS one.

[18]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[19]  A. Ascherio,et al.  Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention , 2008, Seminars in neurology.

[20]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[21]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[22]  J. Kurtzke.  Multiple sclerosis in time and space--geographic clues to cause. , 2000, Journal of neurovirology.

[23]  C. Martyn,et al.  Migrant studies in multiple sclerosis , 1995, Progress in Neurobiology.

[24]  Sander Greenland,et al.  Modern Epidemiology 3rd edition , 1986 .

[25]  J. Kurtzke.  Geography in multiple sclerosis , 1977, Journal of Neurology.

[26]  J. Palo,et al.  Studies on the geographic clustering of multiple sclerosis and optic neuritis in Finland , 1976, Journal of Neurology.

[27]  J. M. Sutherland,et al.  Observations on the prevalence of multiple sclerosis in Northern Scotland. , 1956, Brain : a journal of neurology.

[28]  M. Graffar.  [Modern epidemiology]. , 1971, Bruxelles medical.